FARAH E NASRATY
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology LA JOLLA, CA NPI 1104244813
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CA Alexion Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$8,450.30
- Category: General Payments
- Program years: PY2018–2024
- Record count: 360
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,329.71 across 57 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,329.71 | 57 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $236.19 | 9 |
| Daiichi Sankyo Inc. | $208.59 | 11 |
| PFIZER INC. | $164.84 | 8 |
| BeiGene USA, Inc. | $105.05 | 4 |
| Incyte Corporation | $80.97 | 4 |
| Lilly USA, LLC | $71.26 | 4 |
| TAIHO ONCOLOGY, INC. | $64.05 | 2 |
| Gilead Sciences, Inc. | $47.38 | 2 |
| Merck Sharp & Dohme Corporation | $43.19 | 2 |
| EISAI INC. | $42.77 | 2 |
| SOBI, INC | $40.83 | 1 |
| TerSera Therapeutics LLC | $33.85 | 1 |
| Rigel Pharmaceuticals, Inc. | $33.53 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.96 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.80 | 1 |
| ABBVIE INC. | $27.36 | 1 |
| Deciphera Pharmaceuticals Inc. | $26.44 | 1 |
| SpringWorks Therapeutics, Inc. | $24.52 | 1 |
| Kite Pharma, Inc. | $17.13 | 1 |
By program year
Records — PY2024 (57)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.